The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity
Abstract
Calcineurin, a Ca2+, calmodulin-dependent protein phosphatase, was recently found to bind with high affinity to two different immunosuppressant binding proteins (immunophilins) with absolute dependence on the presence of the immunosuppressants FK506 or cyclosporin A (CsA) [Liu et al. (1991) Cell 66, 807-815]. The binding affinities of the immunophilin-drug complexes toward calcineurin and the stoichiometry of the resultant multimeric complexes have now been determined, and structural elements of FK506, CsA, and calcineurin that are critical for mediating their interactions have been identified. Analogues of FK506 (FK520, FK523, 15-O-demethyl-FK520) and CsA (MeBm2t1-CsA and MeAla6-CsA) whose affinities for their cognate immunophilins do not correlate with their immunosuppressive activities have been prepared and evaluated in biochemical and cellular assays. We demonstrate a strong correlation between the ability of these analogues, when bound to their immunophilins, to inhibit the phosphatase activity of calcineurin and their ability to inhibit transcriptional activation by NF-AT, a T cell specific transcription factor that regulates IL-2 gene synthesis in human T cells. In addition, FKBP-FK506 and CyP-CsA do not inhibit members of the PP1, PP2A, and PP2C classes of serine/threonine phosphatases. These data suggest that calcineurin is the relevant cellular target of these immunosuppressive agents and is involved in Ca(2+)-dependent signal transduction pathways in, among others, T cells and mast cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
Self-citationCyclophilin: A Specific Cytosolic Binding Protein for Cyclosporin A
Handschumacher, R. E., Harding, M. W., Rice, J., Drugge, R. J., & Speicher, D. W. (1984) · Science · doi:10.1126/science.6238408 · Cited by 1,673
Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands
Schreiber, S. L. (1991) · Science · doi:10.1126/science.1702904 · Cited by 1,494
Self-citationCyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins
Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T., & Schmid, F. X. (1989) · Nature · doi:10.1038/337476a0 · Cited by 1,407
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
Harding, M. W., Galat, A., Uehling, D. E., & Schreiber, S. L. (1989) · Nature · doi:10.1038/341758a0 · Cited by 1,396
Self-citationKINO, T., HATANAKA, H., MIYATA, S., INAMURA, N., NISHIYAMA, M., YAJIMA, T., GOTO, T., OKUHARA, M., KOHSAKA, M., AOKI, H., et al. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1256 · Cited by 1,209
Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin
Takahashi, N., Hayano, T., & Suzuki, M. (1989) · Nature · doi:10.1038/337473a0 · Cited by 1,078
Siekierka, J. J., Hung, S. H. Y., Poe, M., Lin, C. S., & Sigal, N. H. (1989) · Nature · doi:10.1038/341755a0 · Cited by 1,010
Bierer, B. E., Mattila, P. S., Standaert, R. F., Herzenberg, L. A., Burakoff, S. J., Crabtree, G., & Schreiber, S. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9231 · Cited by 696
Self-citationCyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T Cell Activation
Emmel, E. A., Verweij, C. L., Durand, D. B., Higgins, K. M., Lacy, E., & Crabtree, G. R. (1989) · Science · doi:10.1126/science.2595372 · Cited by 664
Cited by
The mitochondrial permeability transition pore and its role in cell death
CROMPTON, M. (1999) · Biochemical Journal · doi:10.1042/bj3410233 · Cited by 2,432
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
Clipstone, N. A., & Crabtree, G. R. (1992) · Nature · doi:10.1038/357695a0 · Cited by 1,637
Target identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,096
Gases as biological messengers: nitric oxide and carbon monoxide in the brain
Dawson, T., & Snyder, S. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05147.1994 · Cited by 1,043
Regulation of the Calmodulin-stimulated Protein Phosphatase, Calcineurin
Klee, C. B., Ren, H., & Wang, X. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13367 · Cited by 898
Self-citationControlling Signal Transduction with Synthetic Ligands
Spencer, D. M., Wandless, T. J., Schreiber, S. L., & Crabtree, G. R. (1993) · Science · doi:10.1126/science.7694365 · Cited by 843
Self-citationKunz, J., Henriquez, R., Schneider, U., Deuter-Reinhard, M., Movva, N. R., & Hall, M. N. (1993) · Cell · doi:10.1016/0092-8674(93)90144-f · Cited by 834
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B
Luban, J., Bossolt, K. L., Franke, E. K., Kalpana, G. V., & Goff, S. P. (1993) · Cell · doi:10.1016/0092-8674(93)90637-6 · Cited by 802
Brain ischemia and reperfusion: molecular mechanisms of neuronal injury
White, B. C., Sullivan, J. M., DeGracia, D. J., O’Neil, B. J., Neumar, R. W., Grossman, L. I., Rafols, J. A., & Krause, G. S. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00386-5 · Cited by 796
Sirolimus: its discovery, biological properties, and mechanism of action
Sehgal, S. N. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00211-2 · Cited by 779
Sehgal, S. N. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00045-9 · Cited by 663
MacDonald, A. S. (2001) · Transplantation · doi:10.1097/00007890-200101270-00019 · Cited by 621
Dawson, T. M., Steiner, J. P., Dawson, V. L., Dinerman, J. L., Uhl, G. R., & Snyder, S. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.9808 · Cited by 538
Regulation of Cell Cycle Progression by Calcium/Calmodulin-Dependent Pathways
Kahl, C. R., & Means, A. R. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0008 · Cited by 496
RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.
Chiu, M. I., Katz, H., & Berlin, V (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12574 · Cited by 481
Nicolli, A., Basso, E., Petronilli, V., Wenger, R. M., & Bernardi, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.2185 · Cited by 479
Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia
Sharkey, J., & Butcher, S. P. (1994) · Nature · doi:10.1038/371336a0 · Cited by 455
The Immunophilin FKBP12 Functions as a Common Inhibitor of the TGFβ Family Type I Receptors
Wang, T., Li, B.-Y., Danielson, P. D., Shah, P. C., Rockwell, S., Lechleider, R. J., Martin, J., Manganaro, T., & Donahoe, P. K. (1996) · Cell · doi:10.1016/s0092-8674(00)80116-6 · Cited by 388
FK506 and cyclosporin, molecular probes for studying intracellular signal transduction
Liu, J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90048-p · Cited by 383
Self-citationMechanism of action of the immunosuppressant rapamycin
Dumont, F. J., & Su, Q. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02233-3 · Cited by 358
Peters, D. H., Fitton, A., Plosker, G. L., & Faulds, D. (1993) · Drugs · doi:10.2165/00003495-199346040-00009 · Cited by 356
Yang, J., Rothermel, B., Vega, R. B., Frey, N., McKinsey, T. A., Olson, E. N., Bassel-Duby, R., & Williams, R. S. (2000) · Circulation Research · doi:10.1161/01.res.87.12.e61 · Cited by 354
Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor
Hatada, M. H., Lu, X., Laird, E. R., Green, J., Morgenstern, J. P., Lou, M., Marr, C. S., Phillips, T. B., Ram, M. K., Theriault, K., et al. (1995) · Nature · doi:10.1038/377032a0 · Cited by 346
Shaw, K. T., Ho, A. M., Raghavan, A., Kim, J., Jain, J., Park, J., Sharma, S., Rao, A., & Hogan, P. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11205 · Cited by 345
Peptidylproline cis‐trans‐isomerases: immunophilins
GALAT, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18189.x · Cited by 343
Immunophilin-sensitive protein phosphatase action in cell signaling pathways
Schreiber, S. L. (1992) · Cell · doi:10.1016/0092-8674(92)90158-9 · Cited by 342
Self-citationCalcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B.
Frantz, B., Nordby, E. C., Bren, G., Steffan, N., Paya, C. V., Kincaid, R. L., Tocci, M. J., O'Keefe, S. J., & O'Neill, E. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06329.x · Cited by 334
Signal integration at the level of protein kinases, protein phosphatases and their substrates
Cohen, P. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90010-7 · Cited by 318
Self-citationPeptidyl‐Prolyl cis/trans Isomerases and Their Effectors
Fischer, G. (1994) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199414151 · Cited by 308
A conserved family of calcineurin regulators
Kingsbury, T. J., & Cunningham, K. W. (2000) · Genes & Development · doi:10.1101/gad.14.13.1595 · Cited by 304
Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex
Tai, P.-K. K., Albers, M. W., Chang, H., Faber, L. E., & Schreiber, S. L. (1992) · Science · doi:10.1126/science.1376003 · Cited by 304
Self-citationBaker, E. K., Colley, N. J., & Zuker, C. S. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06816.x · Cited by 302
Calcineurin Binds the Transcription Factor NFAT1 and Reversibly Regulates Its Activity
Loh, C., Shaw, K. T.-Y., Carew, J., Viola, J. P. B., Luo, C., Perrino, B. A., & Rao, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10884 · Cited by 299
Calcineurin: From structure to function
(2001) · Current Topics in Cellular Regulation · doi:10.1016/s0070-2137(01)80011-x · Cited by 298
Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus
MacDonald, A., Scarola, J., Burke, J. T., & Zimmerman, J. J. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)89027-x · Cited by 292
Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia.
Lyons, W. E., George, E. B., Dawson, T. M., Steiner, J. P., & Snyder, S. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3191 · Cited by 285
Bram, R. J., Hung, D. T., Martin, P. K., Schreiber, S. L., & Crabtree, G. R. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4760 · Cited by 277
Self-citationHuai, Q., Kim, H.-Y., Liu, Y., Zhao, Y., Mondragon, A., Liu, J. O., & Ke, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192206699 · Cited by 277
Self-citationCD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A
Pushkarsky, T., Zybarth, G., Dubrovsky, L., Yurchenko, V., Tang, H., Guo, H., Toole, B., Sherry, B., & Bukrinsky, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111583198 · Cited by 270
Grassberger, Baumruker, Enz, Hiestand, Hultsch, Kalthoff, Schuler, Schulz, Werner, Winiski, et al. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02974.x · Cited by 267
Superoxide dismutase protects calcineurin from inactivation
Wang, X., Culotta, V. C., & Klee, C. B. (1996) · Nature · doi:10.1038/383434a0 · Cited by 266
Self-citationRapamycin: an anti-cancer immunosuppressant?
Law, B. K. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.009 · Cited by 252
Calcineurin: Structure, function, and inhibition
Hemenway, C. S., & Heitman, J. (1999) · Cell Biochemistry and Biophysics · doi:10.1007/bf02737887 · Cited by 227
Fox, D. S., Cruz, M. C., Sia, R. A. L., Ke, H., Cox, G. M., Cardenas, M. E., & Heitman, J. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02295.x · Cited by 175
Cruz, M. C., Fox, D. S., & Heitman, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.5.1020 · Cited by 150
Calcineurin is essential in cyclosporin A- and FK506-sensitive yeast strains.
Breuder, T., Hemenway, C. S., Movva, N. R., Cardenas, M. E., & Heitman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5372 · Cited by 135
Rapamycin-inspired macrocycles with new target specificity
Guo, Z., Hong, S. Y., Wang, J., Rehan, S., Liu, W., Peng, H., Das, M., Li, W., Bhat, S., Peiffer, B., et al. (2019) · Nature Chemistry · doi:10.1038/s41557-018-0187-4 · Cited by 120
Self-citationWiederrecht, G., Hung, S., Chan, H. K., Marcy, A., Martin, M., Calaycay, J., Boulton, D., Sigal, N., Kincaid, R. L., & Siekierka, J. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36676-1 · Cited by 115
Renoir, J. M., Mercier-Bodard, C., Hoffmann, K., Le Bihan, S., Ning, Y. M., Sanchez, E. R., Handschumacher, R. E., & Baulieu, E. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4977 · Cited by 94
Potentiation of progesterone receptor-mediated transcription by the immunosuppressant FK506.
Tai, P.-K. K., Albers, M. W., McDonnell, D. P., Chang, H., Schreiber, S. L., & Faber, L. E. (1994) · Biochemistry · doi:10.1021/bi00201a014 · Cited by 52
Self-citation
Metadata
- Authors
- Liu, J., Albers, M. W., Wandless, T. J., Luan, S., Alberg, D. G., Belshaw, P. J., Cohen, P., MacKintosh, C., Klee, C. B., & Schreiber, S. L.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1992-04-28
- Volume
- 31
- Issue
- 16
- Pages
- 3896-3901
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2091538386
- Cited by
- 558
- References
- 38
- FWCI
- 20.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.